article · Journal of the International Association of Providers of AIDS Care (JIAPAC)

Metabolic Syndrome Among People Living With HIV on Dolutegravir and Efavirenz-Based Antiretroviral Therapy in Ethiopia: A Comparative Cross-Sectional Study

Mohammed Jemal
Adane Adugna
Mamaru Getinet
Temesgen Baylie
Deresse Sinamaw
Baye Ashenef
Nuredin Chura Waritu

20245 citationsOpen accessDebre Markos University

Abstract

The prevalence of metabolic syndrome was significantly higher among PLWH on DTG-based regimens. This signifies that DTG-treated patients should be advised on lifestyle adjustments to prevent the development of metabolic syndrome.

Research topics

HIV-related health complications and treatments
Diabetes, Cardiovascular Risks, and Lipoproteins
Diabetes Management and Research

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1177/23259582241303305

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.